WallStreetZenWallStreetZen

NYSE: HAE
Haemonetics Corp Stock Ownership - Who owns Haemonetics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Haemonetics Corp insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Roy GalvinPresident Global Plasma BC2024-11-01161$71.48
$11.51kSell
Laurie A. MillerSVP Human Resources2024-09-17238$76.54
$18.22kSell
Christopher SimonPresident CEO2024-08-2939,704$75.56
$3.00MSell
Stewart W. StrongPresident Global Hospital2024-07-264,312$91.15
$393.04kSell
Stewart W. StrongPresident Global Hospital2024-07-252,798$90.58
$253.44kSell
Anila LingamneniEVP Chief Technology Officer2024-07-1279$90.00
$7.11kSell
Anila LingamneniEVP Chief Technology Officer2024-07-112,136$90.00
$192.24kSell
Christopher SimonPresident CEO2024-06-06104,516$41.64
$4.35MBuy
Christopher SimonPresident CEO2024-06-0671,335$87.38
$6.23MSell
Michelle L. BasilEVP and General Counsel2024-05-298,896$87.86
$781.60kSell

1 of 6

HAE insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when HAE insiders and whales buy or sell their stock.

HAE Shareholders

What type of owners hold Haemonetics Corp stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc12.26%6,159,904$394.05MInstitution
Vanguard Group Inc10.31%5,179,388$331.33MInstitution
Neuberger Berman Group LLC8.80%4,419,343$282.71MInstitution
Capital Research Global Investors8.44%4,238,954$271.17MInstitution
Wellington Management Group LLP7.84%3,940,224$252.06MInstitution
T Rowe Price Investment Management Inc5.08%2,553,814$163.37MInstitution
State Street Corp3.88%1,946,987$124.55MInstitution
Thrivent Financial For Lutherans2.52%1,264,294$80.88MInstitution
Geode Capital Management LLC2.35%1,181,049$75.55MInstitution
Royce Associates LP2.30%1,153,268$73.77MInstitution

1 of 3

HAE vs Medical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
HAE97.58%2.42%Net Selling
ICUI70.72%29.28%Net SellingNet Selling
NVST64.76%35.24%Net SellingNet Selling
XRAY97.62%2.38%Net SellingNet Selling
BLCO9.68%88.59%Net SellingNet Selling
View Top Medical Stocks

Haemonetics Stock Ownership FAQ

Who owns Haemonetics?

Haemonetics (NYSE: HAE) is owned by 113.28% institutional shareholders, 2.81% Haemonetics insiders, and 0.00% retail investors. Blackrock Inc is the largest individual Haemonetics shareholder, owning 6.16M shares representing 12.26% of the company. Blackrock Inc's Haemonetics shares are currently valued at $388.20M.

If you're new to stock investing, here's how to buy Haemonetics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.